These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 19401573

  • 1. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.
    Heesakkers RA, Jager GJ, Hövels AM, de Hoop B, van den Bosch HC, Raat F, Witjes JA, Mulders PF, van der Kaa CH, Barentsz JO.
    Radiology; 2009 May; 251(2):408-14. PubMed ID: 19401573
    [Abstract] [Full Text] [Related]

  • 2. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.
    Heesakkers RA, Hövels AM, Jager GJ, van den Bosch HC, Witjes JA, Raat HP, Severens JL, Adang EM, van der Kaa CH, Fütterer JJ, Barentsz J.
    Lancet Oncol; 2008 Sep; 9(9):850-6. PubMed ID: 18708295
    [Abstract] [Full Text] [Related]

  • 3. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Deserno WM, Harisinghani MG, Taupitz M, Jager GJ, Witjes JA, Mulders PF, Hulsbergen van de Kaa CA, Kaufmann D, Barentsz JO.
    Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
    [Abstract] [Full Text] [Related]

  • 4. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.
    Dinniwell R, Chan P, Czarnota G, Haider MA, Jhaveri K, Jewett M, Fyles A, Jaffray D, Milosevic M.
    Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):844-51. PubMed ID: 19095369
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
    Tatsumi Y, Tanigawa N, Nishimura H, Nomura E, Mabuchi H, Matsuki M, Narabayashi I.
    Gastric Cancer; 2006 Jul 01; 9(2):120-8. PubMed ID: 16767368
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR Imaging at 1.5 and 3.0 T: early experience.
    Heesakkers RA, Fütterer JJ, Hövels AM, van den Bosch HC, Scheenen TW, Hoogeveen YL, Barentsz JO.
    Radiology; 2006 May 01; 239(2):481-7. PubMed ID: 16641354
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
    Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I.
    J Am Coll Surg; 2006 Apr 01; 202(4):604-11. PubMed ID: 16571430
    [Abstract] [Full Text] [Related]

  • 15. Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.
    Ross RW, Zietman AL, Xie W, Coen JJ, Dahl DM, Shipley WU, Kaufman DS, Islam T, Guimaraes AR, Weissleder R, Harisinghani M.
    Clin Imaging; 2009 Apr 01; 33(4):301-5. PubMed ID: 19559353
    [Abstract] [Full Text] [Related]

  • 16. Pearls and pitfalls of MR lymphography in gynecologic malignancy.
    Narayanan P, Iyngkaran T, Sohaib SA, Reznek RH, Rockall AG.
    Radiographics; 2009 Apr 01; 29(4):1057-69; discussion 1069-71. PubMed ID: 19605656
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer.
    Hruby S, Englberger C, Lusuardi L, Schätz T, Kunit T, Abdel-Aal AM, Hager M, Janetschek G.
    J Urol; 2015 Aug 01; 194(2):357-63. PubMed ID: 25896557
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
    Saksena MA, Saokar A, Harisinghani MG.
    Eur J Radiol; 2006 Jun 01; 58(3):367-74. PubMed ID: 16472955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.